One-Dose drug may clear path to second kidney transplant
NCT ID NCT04779957
First seen Jan 02, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tested whether a single dose of tocilizumab, given right before or after removing a failed kidney transplant, can safely lower the immune system's production of antibodies that make a second transplant difficult. 18 adults who needed their graft removed and hoped for another transplant took part. The main goal was to check for serious infections, while also seeing if the drug reduced harmful antibodies one year later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.